| Literature DB >> 19647907 |
Grazyna Groszek1, Agnieszka Nowak-Król, Tomasz Wdowik, Dariusz Swierczyński, Marek Bednarski, Monika Otto, Maria Walczak, Barbara Filipek.
Abstract
The synthesis of (2RS)-1-(5-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol and (2RS)-1-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol and its enantiomers, analogs of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol ((RS)-9) is described. Compounds were tested for electrographic, antiarrhythmic, hypotensive and spasmolytic activities as well as for alpha(1)-, alpha(2)- and beta(1)-adrenoceptors binding affinities. The antagonist potency of the new compounds was compared with carvedilol and (RS)-9.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19647907 DOI: 10.1016/j.ejmech.2009.07.012
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514